VERONA PHARMA PLC's ticker is VRNA and the CUSIP is 925050106. A total of 38 filers reported holding VERONA PHARMA PLC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $138,000 | +23.2% | 13,446 | -50.6% | 0.07% | +35.2% |
| Q2 2022 | $112,000 | -37.4% | 27,196 | -23.7% | 0.05% | -18.2% |
| Q1 2022 | $179,000 | -21.8% | 35,656 | +4.5% | 0.07% | -14.3% |
| Q4 2021 | $229,000 | +26.5% | 34,106 | +2.9% | 0.08% | +16.7% |
| Q3 2021 | $181,000 | +74.0% | 33,156 | +113.8% | 0.07% | +61.0% |
| Q2 2021 | $104,000 | -11.9% | 15,506 | +10.0% | 0.04% | -18.0% |
| Q1 2021 | $118,000 | – | 14,102 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 4,249,918 | $69,273,663 | 7.59% |
| Aisling Capital Management LP | 1,115,352 | $18,180,238 | 7.49% |
| NEA Management Company, LLC | 5,108,563 | $91,031,474 | 7.03% |
| Octagon Capital Advisors LP | 2,369,000 | $38,614,700 | 5.93% |
| Knoll Capital Management, LLC | 200,000 | $3,260,000 | 3.38% |
| Frazier Life Sciences Management, L.P. | 3,014,349 | $49,133,889 | 3.26% |
| Perceptive Advisors | 4,007,197 | $65,317,311 | 2.18% |
| RA Capital Management | 6,317,990 | $102,983,237 | 2.03% |
| Deep Track Capital, LP | 3,187,415 | $51,954,865 | 2.00% |
| Carlyle Group Inc. | 2,457,500 | $40,008,100 | 1.74% |